Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Imaging| October 12, 2016

The Promise Ahead for Radiology


Image courtesy of Pixabay

We know where imaging has been.

We think it’s going to a better place. But exactly when it will get there and what it will look like when it arrives are tough to say. We think the new imaging is going to make radiologists very relevant. It’s going to make medicine more efficient. And it’s going to make patient care better. 

This future will come when imaging “puts the patient first,” as the RSNA says. It will be part of what people are calling “value medicine,” a term that is difficult to define exactly. And it may be easier to define than achieve.

Simply put, value medicine is the practice of medicine that delivers a better outcome for patients as it pushes costs down. It’s efficient. It’s effective. And it’s what everybody wants to hear.

Like world peace, it’s hard to find anybody against it. And, also like world peace, it is a long way from where we now are.


Rule Out Medicine

Modern medicine is all about ruling out what’s not wrong. Doctors who hear hoofsteps may think horses before zebras — but there are a lot of different types of horses. The “if, then” decision-making can be a lot like the game of Mousetrap before — finally — the cage comes down on the truth.

A couple years ago, I walked into my doctor’s office strongly suspecting a torn rotator cuff in my right shoulder. The nurse told me I’d be going first to radiography, which — lucky for me — was just down the hall. I said no. My doctor, who knows me well, told the nurse I would balk. And, really, my position was unassailable.

My symptoms clearly indicated soft tissue damage, something radiography would not show. I needed an MRI, I said. And, in the end, I got one … but not until being X-rayed.

In the end, the insurance company paid more than was needed and I got unnecessary radiation. The radiographs showed great looking bones; the MRI torn muscles. And, a few months after surgery, my arm was moving like it had before.


A Sea Of Giant Question Marks

And yet, I wondered, in cases similar to mine, does radiography ever do the trick? Does it find fractures and eliminate the need for an MRI? Or are MRIs ordered anyway, if for no other reason than to rule out soft tissue damage? Could there be a fracture — and torn muscles? Would it have made more sense to begin with MRI, which — without using ionizing radiation — can pick up even subtle signs of a stress fracture, as well as soft tissue damage? 

They are giant question marks adrift in a sea of many others. Will value medicine replace them with periods? Even exclamation points?

Maybe. If the right questions are asked. And there’s money to dive deep into data. And clinical researchers are willing to take on the questions. And practitioners are willing to change protocol, if one is indicated.

This last consideration may be the toughest of all.

Recently the Center for Medicare and Medicaid (CMS) informed American providers that its payments for film and computed radiography (CR) exams will soon be reduced in favor of those done with digital flat panels. If X-ray demand goes down, providers depending on increased demand to gain a reasonable return on their investments in digital radiography are going to be disappointed.

And what of ultrasound? And echo; angio and cardiac cath; scintigraphy and SPECT, both of which have something to offer; PET/CT and plain old CT — and spectral CT; and, of course, MRI?

Where will all these fit?

It’s going to be a sticky wicket, to be sure. The adoption of value medicine is shaping up to be a promising — but long — slog.

The first battles will be picked for their likelihood to demonstrate real gains. Those gains will be thoroughly documented; implemented; and, after follow-up has demonstrated beyond a shadow of a doubt what everyone expected would be the case, they will be pressed as examples of why value medicine makes sense. And why it should be further pursued. And the slog will continue.

Slowly, the gears of medical practice will be swapped out. Years of virtually imperceptible change will pass and, then, if all goes according to plan, medical practice will change. Will medicine be more efficient and effective? Will imaging have fomented this change? Maybe.

And, maybe, MRI will be the go-to exam for patients suspected of rotator cuff injury.

If I’m lucky, it will happen before I need my other shoulder done. Unfortunately … I’m beginning to feel a bit of a twinge.


Editor's note: This is the second blog in a four-part series on State-of-the-art Radiology. The first blog, "When Will the Greatest Trend in Radiology Happen?" can be found here.

Related Content

Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Sponsored Content | Case Study | Imaging | March 06, 2018
As one of the largest Catholic, not-for-profit healthcare systems in the United States, St. Louis-based SSM Health has...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Carestream Supplies Wireless Digital X-ray Detectors for 2018 NFL Combine
News | Digital Radiography (DR) | February 27, 2018
In addition to demonstrating their speed, agility and strength at the 2018 National Football League (NFL) Scouting...
Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Overlay Init